Across the world, the impact of the COVID-19 pandemic on access to cancer diagnosis and subsequent clinical services has been profound. In regions with widespread community transmission of the disease, this impact endured throughout 2020 and into 2021, and has resulted in a significant backlog of under-diagnosed and under-treated disease in these regions.
Members of the C3 Research Group have actively supported the work of Te Aho o Te Kahu – Cancer Control Agency to mitigate the impact of the pandemic on cancer services in New Zealand. We have done this through membership of the Agency's COVID-19 Data Response Advisory Group, and by assisting with monitoring the impact of COVID-19 on cancer care and outcomes in New Zealand.
Visit our COVID-19 impact on cancer care publications in OUR Archive